Browse > Article

Chronic Kidney Disease as an Independent Risk Factor for Thromboembolism in Patients with Atrial Fibrillation  

Oh, Gyu-Chul (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Cha, Myung-Jin (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Kang, Do-Yoon (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Kim, Ji-Yeong (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Sung, Young-Jun (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Yoon, Jung-Han (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Lee, Dong-Won (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Lee, Min-Ho (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Choe, Won-Seok (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Choi, Eue-Keun (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Oh, Se-Il (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Publication Information
The Korean Journal of Medicine / v.81, no.4, 2011 , pp. 464-469 More about this Journal
Abstract
Background/Aims: The $CHADS_{2}$ scoring system has been widely used to stratify thromboembolic risk associated with atrial fibrillation. Chronic kidney disease (CKD) is associated with increased risk of stroke in patients with atrial fibrillation (AF) but has not yet been included in risk-scoring systems. We analyzed the difference in thromboembolic risk of patients with AF and a moderate risk of stroke according to the presence of CKD. Methods: Of 1,952 patients with AF, 451 with a $CHADS_{2}$ score of 1 were divided into two groups according to the presence of CKD, and thromboembolic events were analyzed. Each group was further classified by the antithrombotic regimen used: warfarin or aspirin. Results: Of the 451 patients, 94 with CKD had a significantly higher risk for thromboembolic complications than the 357 patients without CKD (hazard ratio [HR], 3.630; 95% confidence interval [CI], 1.565-8.422; p = 0.003). Patients with CKD who were on aspirin had a higher risk for thromboembolic events than those on warfarin (HR, 5.203; 95% CI, 1.056-25.633, p = 0.043). However, in patients without CKD, the aspirin group did not have a higher risk of thromboembolic events than the warfarin group (HR, 0.803; 95% CI, 0.225-2.867, p = 0.735). Conclusions: In Korean patients with AF and a $CHADS_{2}$ score of 1, CKD may be an independent thromboembolic risk factor. In patients with CKD, warfarin may be superior to aspirin for lowering thromboembolic risk.
Keywords
Atrial fibrillation; Thromboembolism; Renal insufficiency, Chronic;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.   DOI   ScienceOn
2 Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.   DOI   ScienceOn
3 Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.   DOI   ScienceOn
4 Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354.   DOI   ScienceOn
5 Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2005;112:1687-1691.   DOI   ScienceOn
6 Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials: the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999;30:1223-1229.   DOI   ScienceOn
7 Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled clinical trials. Arch Intern Med 1994;154:1449-1457.   DOI   ScienceOn
8 van Walraven C, Hart RG, Wells GA, et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003;163:936-943.   DOI   ScienceOn
9 Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429.   DOI   ScienceOn
10 Hart RG, Pearce LA, Aguilar MI. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med 2007;147:590-592.
11 Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.   DOI   ScienceOn
12 Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2009;119:1363-1369.   DOI   ScienceOn
13 Seliger SL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003;64:603-609.   DOI   ScienceOn
14 Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.   DOI   ScienceOn
15 Khella SL. New insights into stroke in chronic kidney disease. Adv Chronic Kidney Dis 2008;15:338-346.   DOI   ScienceOn